Urquhart P, Nicolaou A, Woodward D F
Manchester Pharmacy School, Faculty of Medical and Human Sciences, Stopford Building, Oxford Road, The University of Manchester, M13 9PT, UK.
Manchester Pharmacy School, Faculty of Medical and Human Sciences, Stopford Building, Oxford Road, The University of Manchester, M13 9PT, UK.
Biochim Biophys Acta. 2015 Apr;1851(4):366-76. doi: 10.1016/j.bbalip.2014.12.015. Epub 2014 Dec 24.
The naturally occurring mammalian endocannabinoids possess biological attributes that extend beyond interaction with cannabinoid receptors. These extended biological properties are the result of oxidative metabolism of the principal mammalian endocannabinoids arachidonoyl ethanolamide (anandamide; A-EA) and 2-arachidonoylglycerol (2-AG). Both endocannabinoids are oxidized by cyclo-oxygenase-2 (COX-2), but not by COX-1, to a series of prostaglandin derivatives (PGs) with quite different biological properties from those of the parent substrates. PG ethanolamides (prostamides, PG-EAs) and PG glyceryl esters (PG-Gs) are not only pharmacologically distinct from their parent endocannabinoids, they are distinct from the corresponding acidic PGs, and are differentiated from each other. Ethanolamides and glyceryl esters of the major prostanoids PGD2, PGE2, PGF2α, and PGI2 are formed by the various PG synthases, and thromboxane ethanolamides and glyceryl esters are not similarly produced. COX-2 is also of interest by virtue of its corollary central role in modulating endocannabinoid tone, providing a new therapeutic approach for treating pain and anxiety. Other major oxidative conversion pathways are provided for both A-EA and 2-AG by several lipoxygenases (LOXs), resulting in the formation of numerous hydroxyl metabolites. These do not necessarily represent inactivation pathways for endocannabinoids but may mimic or modulate the endocannabinoids or even display alternative pharmacology. Similarly, A-EA and 2-AG may be oxidized by P450 enzymes. Again a very diverse number of metabolites are formed, with either cannabinoid-like biological properties or an introduction of disparate pharmacology. The biological activity of epoxy and hydroxyl derivatives of the endocannabinoids remains to be fully elucidated. This review attempts to consolidate and compare the findings obtained to date in an increasingly important research area. This article is part of a Special Issue entitled "Oxygenated metabolism of PUFA: analysis and biological relevance".
天然存在的哺乳动物内源性大麻素具有一些生物学特性,这些特性超出了与大麻素受体相互作用的范畴。这些扩展的生物学特性是主要的哺乳动物内源性大麻素花生四烯酸乙醇酰胺(阿南达米德;A-EA)和2-花生四烯酸甘油酯(2-AG)氧化代谢的结果。这两种内源性大麻素都被环氧化酶-2(COX-2)氧化,但不被COX-1氧化,生成一系列与母体底物生物学特性截然不同的前列腺素衍生物(PGs)。PG乙醇酰胺(前列腺酰胺,PG-EAs)和PG甘油酯(PG-Gs)不仅在药理学上与其母体内源性大麻素不同,它们与相应的酸性PGs也不同,并且彼此之间也有区别。主要前列腺素PGD2、PGE2、PGF2α和PGI2的乙醇酰胺和甘油酯由各种PG合成酶形成,而血栓素乙醇酰胺和甘油酯则不会以类似方式产生。COX-2因其在调节内源性大麻素水平方面的核心作用而备受关注,为治疗疼痛和焦虑提供了一种新的治疗方法。几种脂氧合酶(LOXs)为A-EA和2-AG提供了其他主要的氧化转化途径,导致形成大量羟基代谢产物。这些不一定代表内源性大麻素的失活途径,但可能模拟或调节内源性大麻素,甚至展现出不同的药理学特性。同样,A-EA和2-AG可能被细胞色素P450酶氧化。同样会形成非常多样的代谢产物,具有类似大麻素的生物学特性或引入不同的药理学特性。内源性大麻素的环氧和羟基衍生物的生物学活性仍有待充分阐明。本综述试图整合和比较在这个日益重要的研究领域中迄今获得的研究结果。本文是名为“多不饱和脂肪酸的氧化代谢:分析与生物学意义”的特刊的一部分。